Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic/Weigao Joint Venture Could Boost Firms’ Ortho Presence In China

This article was originally published in The Gray Sheet

Executive Summary

Medtronic is in the final stages of negotiating a joint venture with China-based device maker Shandong Weigao that could give Medtronic a 15% stake in the company for about $220 million

You may also be interested in...



Medtronic Boosts Ortho Presence In China Under Weigao Joint Venture

Medtronic's joint venture with device maker Shandong Weigao gives Medtronic a 15% stake in the Chinese firm

Medtronic Boosts Ortho Presence In China Under Weigao Joint Venture

Medtronic's joint venture with device maker Shandong Weigao gives Medtronic a 15% stake in the Chinese firm

Medtronic Prestige Cervical Disc Rollout Marks 800 Surgeons Trained To Date

Medtronic has trained over 800 surgeons to date on the use of its Prestige artificial cervical disc and will train 200 more each weekend "for the next several weeks," the firm reported Aug. 21 during its fiscal 2008 first quarter earnings call

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel